Results 51 to 60 of about 11,119 (206)

Epidemiology of hidradenitis suppurativa in Poland in relation to international data

Przegląd Dermatologiczny, 2017
Hidradenitis suppurativa (acne inversa) is a chronic, inflammatory, recurrent, debilitating disease of hair follicles manifested by painful, deepseated, inflamed lesions localized in intertriginous areas.
Łukasz Matusiak, Andrzej Kaszuba, Dorota Krasowska, Waldemar Placek, Jacek Szepietowski   +4 more
doaj   +1 more source

Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology [PDF]

Anais Brasileiros de Dermatologia, 2019
: Hidradenitis suppurativa is a chronic immune mediated disease of universal distribution that causes great damage to the quality of life of the affected individual, whose prevalence is estimated at 0.41% in the Brazilian population.
Renata Ferreira Magalhães, Maria Cecília Rivitti-Machado, Gleison Vieira Duarte, Roberto Souto, Daniel Holthausen Nunes, Mario Chaves, Sérgio Henrique Hirata, Andrea Machado Coelho Ramos   +7 more
doaj   +1 more source

Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos, Line Kibsgaard, Trine Bertelsen   +2 more
wiley   +1 more source

Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013 [PDF]

, 2016
International audienceHidradenitis suppurativa (HS) is a frequent chronic inflammatory skin disease typically characterized by recurrent painful, deep inflammatory nodules of the axillary, breast, groin and gluteal areas.
Amelot, F., Aubin, F., Bachelez, H., Beylot Barry, M., Caux, F., Chosidow, O., Dupin, N., Dupuy, A., Hotz, C., Humbert, P., Ingen-Housz-Oro, S., Lepesant, P., Mahé, E., Maruani, A., Modiano, P., Paul, C., Sbidian, E., Seneschal, J., Wolkenstein, P.   +18 more
core   +4 more sources

Metascoring Hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, 2020
info:eu-repo/semantics ...
M. Daoud, H. Njimi, F. Benhadou, M. Suppa, M. Daxhelet, J. Karama, J. White, G.B.E. Jemec, V. del Marmol   +8 more
openaire   +4 more sources

Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections

SAGE Open Medical Case Reports, 2018
Introduction: Hidradenitis suppurativa and synovitis, acne, pustulosis, hyperostosis, osteitis syndrome are chronic, debilitating diseases involving apocrine gland-bearing skin inflammation and bone inflammation, respectively. Although both often present
Erika L Crowley, Ashley O’Toole, Melinda J Gooderham   +2 more
doaj   +1 more source

Characteristics and Clinical Outcomes of Patients With Hidradenitis Suppurativa (HS) Treated With Bimekizumab: A Canadian Retrospective Chart Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterised by painful nodules, abscesses, and draining and non‐draining tunnels. Currently, there are two biologics approved in Canada for the treatment of moderate‐to‐severe HS, adalimumab (anti‐TNF) and secukinumab (anti‐IL‐17A).
Irina Turchin, Tracey Brown‐Maher, Hélène Veillette, David O. Croitoru, Kyle Cullingham   +4 more
wiley   +1 more source

New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa

JEADV Clinical Practice, EarlyView.
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin disease that has historically been underdiagnosed and, until recently, under‐researched. Furthermore, the pathophysiology of HS is complex, and not fully understood. Just three biologic medications—adalimumab (anti‐TNF‐α), secukinumab (anti‐IL17A) and bimekizumab (anti‐IL17A/F) are licensed
Emily Pender, Rosalind Hughes, Brian Kirby   +2 more
wiley   +1 more source

Hidradenitis Suppurativa : clinical studies with focus on evaluation [PDF]

, 2010
Hidradenitis suppurativa (HS) is a chronic inflammatory disease of mainly unknown aetiology which in most cases involves axillae or groins and that can last for decades.
Sartorius, Karin
core  

Leflunomide-Induced Hidradenitis Suppurativa

Case Reports in Rheumatology, 2020
Hidradenitis suppurativa is an inflammatory disease of the pilosebaceous unit with a chronic intermittent course and a devastating effect on quality of life. Rare reports of drug-induced hidradenitis suppurativa exist.
Achraf Machan, Hasna Azendour, Hamza Toufik, Lahsen Achemlal, Mohammed Boui, Naoufal Hjira   +5 more
doaj   +1 more source